MedTrace Logo

Cardiogenic Shock Working Group Registry

NCT04682483 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-06-06

No results posted yet for this study

Summary

The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.

Conditions

  • Cardiogenic Shock

Interventions

DRUG

Vasopressor

The vasopressors include phenylephrine, norepinephrine, epinephrine, dopamine and vasopressin.

DRUG

Inotrope

Inotropes include dobutamine and milrinone.

DEVICE

Acute Mechanical Circulatory Support Devices

Acute Mechanical Circulatory Support devices include ECMO (VV), ECMO (VA), Impella CP, Impella 2.5, Impella 5.0, Impella 5.5, Impella RP, IABP, Centrimag, Tandem Heart and ProTek Duo.

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Abiomed Inc.

    collaborator INDUSTRY

  • Getinge Group

    collaborator OTHER

  • Tufts Medical Center

    lead OTHER

Principal Investigators

  • Reshad Garan, MD · Beth Israel Deaconess Medical Center

  • Claudius Mahr, DO · University of Washington

  • Jaime Hernandez-Montfort, MD · Cleveland Clinic Foundation-Florida

  • Daniel Burkhoff, MD PhD · CardioVascular Research Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-04
Primary Completion
2026-01-01
Completion
2026-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04682483 on ClinicalTrials.gov